112 results
DEFM14A
IMGN
Immunogen, Inc.
2 Jan 24
Proxy related to merger
4:26pm
contractor of the Company or any of its subsidiaries;
adopt, enter into, or amend any collective bargaining agreement or contract with any labor union, trade … that a member state of the European Union or the EC is making, or has made, a referral of the Merger to the EC under Article 22 of the EU Merger Regulation
PREM14A
IMGN
Immunogen, Inc.
21 Dec 23
Preliminary proxy related to merger
4:52pm
, enter into or amend any collective bargaining agreement or contract with any labor union, trade organization or other employee representative body … ) the European Commission (the “EC”) indicates in writing to AbbVie that a member state of the European Union or the EC is making, or has made
DEFA14A
EX-99.1
IMGN
Immunogen, Inc.
30 Nov 23
Additional proxy soliciting materials
4:07pm
the MIRASOL confirmatory trial will support a Marketing Authorization Application (MAA) to the European Union and a supplemental Biologic License
DEFA14A
EX-2.1
IMGN
Immunogen, Inc.
30 Nov 23
Additional proxy soliciting materials
4:07pm
enterprise other than the Company’s Subsidiaries;
(iii) collective bargaining agreement or Contract with any labor union, trade organization or other … with a labor union, works council or other employee representative body. Neither the Company nor any of its Subsidiaries has experienced any picketing
8-K
EX-2.1
IMGN
Immunogen, Inc.
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
4:05pm
enterprise other than the Company’s Subsidiaries;
(iii) collective bargaining agreement or Contract with any labor union, trade organization or other … with a labor union, works council or other employee representative body. Neither the Company nor any of its Subsidiaries has experienced any picketing
8-K
EX-99.1
s8o4y0
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
4:05pm
8-K
EX-1.1
4w52v6wz 5x5m0xca
5 May 23
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-1.1
dbbmbn9
3 Dec 21
Entry into a Material Definitive Agreement
4:07pm
8-K
EX-99.3
7jirec4gd 94vmc25
3 Dec 21
Entry into a Material Definitive Agreement
4:07pm